Infinity Pharmaceuticals, Inc. (INFIQ)
 OTCMKTS  · Delayed Price · Currency is USD  
0.0001
 0.00 (0.00%)
  Oct 29, 2025, 4:00 PM EDT
Infinity Pharmaceuticals Revenue
Infinity Pharmaceuticals had revenue of $583.00K in the quarter ending June 30, 2023, a decrease of -15.01%. This brings the company's revenue in the last twelve months to $2.57M, up 15.88% year-over-year. In the year 2022, Infinity Pharmaceuticals had annual revenue of $2.59M with 39.56% growth.
Revenue (ttm) 
 2.57M
Revenue Growth 
 +15.88%
P/S Ratio 
 0.04
Revenue / Employee 
 85.63K
Employees 
 30
Market Cap 
90.76K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2022 | 2.59M | 735.00K | 39.56% | 
| Dec 31, 2021 | 1.86M | 139.00K | 8.09% | 
| Dec 31, 2020 | 1.72M | -1.33M | -43.62% | 
| Dec 31, 2019 | 3.05M | -19.10M | -86.23% | 
| Dec 31, 2018 | 22.15M | 16.15M | 269.10% | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| American Oncology Network | 1.76B | 
| Veradigm | 588.02M | 
| Jushi Holdings | 256.36M | 
| Glass House Brands | 221.55M | 
| Elite Pharmaceuticals | 105.45M | 
| Silence Therapeutics | 27.17M | 
| Nuo Therapeutics | 1.95M | 
| Northwest Biotherapeutics | 1.09M |